Algo version: 0.98b
Divi's Laboratories is listed at the NSE Exchange
Divi's Laboratories [DIVISLAB.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Divi's Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Divi's Laboratories pays dividends. Last time was Wednesday 11th of September 2024 where the investors holding the stock on Friday 2nd of August 2024 were paid INR30 per share. Over the last 22 times between 2003 and 2024, Divi's Laboratories has paid INR308 with an average of INR14 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Divi's Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 627.15, you would have made a profit of INR3 510.65 per share or 215.75%

Yes, the average daily trading liquidity for Divi's Laboratories is INR534 620 thousand. You should therefore be able to get in and out of your positions relatively fast.

Divi's Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 246.68, the company's ability to pay off the debt is good. Divi's Laboratories has a very good net profit margin of 20.37% and should have very high tolerances against inflation.

We have calculated the inflation risk for Divi's Laboratories to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.